您的位置: 首页 > 农业专利 > 详情页

Novel Vaccine Adjuvants Based on Targeting Adjuvants to Antibodies Directly to Antigen-Presenting Cells
专利权人:
Jacques F. Banchereau;Anne-Laure Flamar;Robert R. Kane;Gerard Zurawski
发明人:
Gerard Zurawski,Jacques F. Banchereau,Anne-Laure Flamar,Robert R. Kane
申请号:
US13415564
公开号:
US20120231023A1
申请日:
2012.03.08
申请国别(地区):
US
年份:
2012
代理人:
摘要:
The present invention includes compositions and methods for enhancing an immune response with an adjuvant composition comprising: an anti-dendritic cell (DC)-specific antibody or fragment thereof conjugated to at least a portion of Toll-Like Receptor (TLR) agonist, more specifically a TLR7 ligand (TLR7L), and a pharmaceutically acceptable carrier, wherein the conjugate and agonist are each comprised in an amount such that, in combination with the other, are effective to produce the immune response in a human or animal subject in need of immunostimulation.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充